logo
Select company
Select metric
-1399.7%EBITDA Margin
VS
Market
5
Sector
17
Industry
32
History
100
$ 3.41Close
$ 1.66 - $ 3.9 52-Week Range
Ticker Information

Ticker

NUVB

Company Name

NUVATION BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSE

NUVATION BIO INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NUVB - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -200.93M-1399.7%$ 14.36M
3/31/2025$ -605.02M-5521.79%$ 10.96M
12/31/2024$ -567.09M-7202.93%$ 7.87M
9/30/2024$ -531.65M-24590.56%$ 2.16M
6/30/2024$ -510.29M-35559.93%$ 1.44M
3/31/2024$ -68.73M0%$ 0
12/31/2023$ -75.65M0%$ 0
9/30/2023$ -82.63M0%$ 0
6/30/2023$ -90.01M0%$ 0
3/31/2023$ -104.16M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NUVATION BIO INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
  • Over the past 5 years, NUVATION BIO INC's average EBITDA % has been -14854.98%.
  • The median EBITDA % for NUVATION BIO INC during this period was -7202.93%
  • NUVATION BIO INC reached its highest EBITDA % over the past 5 years at -1399.7%.
  • The lowest EBITDA % recorded by NUVATION BIO INC in the same timeframe -35559.93%

NUVATION BIO INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
QURE : UNIQURE NV -833.95%ZBIO : ZENAS BIOPHARMA INC -1172.19%ABUS : ARBUTUS BIOPHARMA CORP -344.62%IMNM : IMMUNOME INC -1666.33%VIR : VIR BIOTECHNOLOGY INC -2808.94%TSHA : TAYSHA GENE THERAPIES INC -1114.29%CAPR : CAPRICOR THERAPEUTICS INC -510.35%RLAY : RELAY THERAPEUTICS INC -3669.67%BCYC : BICYCLE THERAPEUTICS PLC -1248.97%TNGX : TANGO THERAPEUTICS INC -572%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for NUVATION BIO INC is calculated as follows: EBITDA [ $ -41.56M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

NUVB - EBITDA Margin, Last 5 years

-35559.93%

Minimum

Jun 30, 2024

-1399.7%

Maximum

Jun 30, 2025

-14854.98%

Average

-7202.93%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.88%